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Abstract
Background: In northern Tunisia, the co-circulation of two related sand fly-borne phleboviruses, Toscana virus (TOSV) and
Punique virus (PUNV) was previously demonstrated. In contrast to TOSV, a prominent human pathogen, there is no data
supporting that PUNV is capable to infect and cause disease to humans. We studied the respective involvement of TOSV
and PUNV in human infections in northern Tunisia through a seroprevalence study.
Methods: The presence of TOSV and PUNV neutralising antibodies (NT-Ab) was tested in human sera collected from 5
districts of the governorate of Bizerte, and the titres of NT-Ab were estimated by microneutralisation (MN) assay.
Principal Findings: A total of 1,273 sera were processed. TOSV and PUNV NT-Ab were detected in 522 (41%) and 111 sera
(8.72%) respectively. TOSV seroprevalence varied from 17.2% to 59.4% depending on the district. Analysis of TOSV
geometric mean titre values demonstrated a constant increase according to the age. The vast majority of sera containing
NT-Ab were found to be more reactive toward TOSV than PUNV. Indeed, past infections with PUNV and TOSV were
undisputable for 5 and 414 sera, respectively.
Conclusions: PUNV may be capable to infect humans but at a low rate. TOSV is responsible for the vast majority of human
infections by sand fly-borne phleboviruses in northern Tunisia. TOSV must be considered by physician and tested in
diagnostic laboratories for patients with meningitis and unexplained fever in northern Tunisia.
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Introduction
The risk of human infection with sand fly-transmitted viruses
has been shown to cover extended geographic areas (southern
Europe, Africa, Middle-East, central and western Asia) because of
the presence of the sand fly vectors [1]. In countries bordering the
Mediterranean basin, phlebotomine sand flies are involved in the
transmission of several arthropod-borne viruses that belong to the
genus Phlebovirus within the Bunyaviridae family. These sand fly-
borne phleboviruses belong to three distinct serocomplexes : (i) the
Sandfly fever Naples virus serocomplex including Toscana virus
(TOSV) and related viruses (Naples, Tehran, Massilia, Granada,
Punique…), (ii) the Sandfly fever Sicilian virus serocomplex including
Sicilian virus and related viruses (Cyprus, Turkey…), and (iii) the
Salehabad virus serocomplex including Salehabad virus and related
viruses (Arbia, Adria…) [2]. Several of those viruses are recognised
human pathogens (TOSV, Naples virus, Sicilian virus, Cyprus
virus and Adria virus) [1,3,4,5]. Recent studies (case reports,
seroprevalence studies and virus isolation) indicate that TOSV
circulates actively in the Mediterranean area. TOSV is the only
sand fly-borne phlebovirus which has been undoubtedly identified
as an aetiological agent of neuroinvasive infections such as
meningitis, meningo-encephalitis or peripheral neurological man-
ifestations [6,7,8]. In Northern Mediterranean countries, infec-
tions due to TOSV represent an important public health problem
as it is one of the major viral pathogens involved in aseptic
PLOS Neglected Tropical Diseases | www.plosntds.org 1 September 2013 | Volume 7 | Issue 9 | e2429
meningitis during the warm season, i.e. between April and October
[9,10,11].
Recent discoveries of new sand fly-borne phleboviruses from
Mediterranean countries has indicated that the viral diversity in
genus the Phlebovirus is higher than initially suspected
[12,13,14,15]. In Tunisia, the recent isolation a new phlebovirus
named Punique virus (PUNV), from phlebotomine sand flies
collected in the north of the country raised the question of its
potential implication as a human pathogen [13]. Indeed, PUNV is
antigenically and genetically closely related to but distinct from
TOSV, and subsequently, it was included in the species Sandfly fever
Naples virus. However, there is currently no additional evidence
suggesting that PUNV is capable to infect and cause disease to
humans. Recently, TOSV was suspected to circulate in Tunisia
based on serological study [16]. These serological findings were
corroborated by the recent isolation of TOSV from sand flies
collected in Northern Tunisia [17].
The objective of the present work was to evaluate and to
compare the respective involvement of TOSV and PUNV through
a seroprevalence study in human, among a population at risk for
sand fly-transmitted diseases originated from Northern Tunisia, by
using the two viruses in a comparative manner through a
microneutralisation (MN) assay.
Materials and Methods
Serum samples
Sera were collected from February to April, 2011, from out care
patients visiting local hospitals for medical reasons that were not
available to us and requiring blood analysis. These patients are
originated from 5 districts (Mateur, Utique, Joumine, Sejenane
and Ras Jabel) of the governorate of Bizerte, Northern Tunisia
located in the vicinity of the site where TOSV and PUNV were
isolated repeatedly from sand flies in 2008, 2009, 2010 (Figure 1)
[13,17].
This study was performed with leftovers of these samples. The
tubes were anonymized and only the sex, age and district
address were recorded. This study was approved by the ethical
committees of the Pasteur Institute of Tunis under the
agreement number IPT/UESV/19/2010, and of the
Marseille Federation of Research No 48 under the number
13-008.
Microneutralisation of TOSV and PUNV
The virus microneutralisation (MN) assay, previously described
for phleboviruses [18], was adapted with minor modifications.
Briefly, MN assay was performed in 96-well microtitre plates
using Vero cells (ATCC CCL81). Two-fold serial dilutions from
1:10 to 1:80 were prepared for each serum and a volume of
50 mL was pipeted into 96-well plates, using an epMotion 5075
working station (Eppendorf). The two virus strains were (i)
Toscana virus strain MRS2010-4319501 (GenBank accession
nos KC776214–KC776216) isolated from a human case of
meningitis in Southeastern France in 2010 [19], and (ii) Punique
virus T101 isolated from Phlebotomus sp. in Tunisia in 2009 (Strain
Tunisie2009T101). The two virus strains were titrated in Vero
cells. A volume of 50 mL containing 100 TCID50 was added into
each well except for the controls that consisted of PBS. The plate
containing 100 TCID50 of virus and the four two-fold dilutions
(1:10 to 1:80) of serum was incubated at 37uC for one hour.
Then, a 50 mL suspension of Vero cells containing approximately
2.105 cells in 5% foetal bovine serum was added to each well, and
incubated at 37uC in presence of 5% CO2. After 5 days, the
microplates were read under an inverted microscope, and the
presence or absence of cytopathic effect was noted. The titre (no
neutralisation, neutralisation at 1:10, 1:20, 1:40 and 1:80) was
recorded.
Interpretation of MN results
The threshold for positivity was defined as 1:20. Differences in
titres lower than four-fold dilutions were considered as not
significantly different. Serum exhibiting paired results such as
neg/$1:20, 1:10/1:20, 1:10/$1:40, and 1:20/$1:80 were
indicative of a single infection against the virus corresponding to
the highest dilution. Serum exhibiting paired results such as neg/
1:10, were considered as negative for both viruses. Serum
exhibiting paired results such as 1:20/1:40, and 1:40/1:80 were
indicative of past infection with both viruses.
Geometric Means of Titres (GMT)
The GMT observed in MN with TOSV and PUNV were
calculated respectively. Sera exhibiting an absence of neutralisa-
tion were attributed a score of 5. Sera exhibiting neutralising
properties were attributed the reciprocal of the dilution (10, 20, 40
or 80). Dilutions $1:160 were not tested since long range analysis
(1:10 to 1:2560) of 100 randomly sorted sera indicated that titres
$160 were seldom observed.
Results
Sera collection and characteristics of the population
A total of 1,273 sera (corresponding to 345 men and 928
women, sex ratio 0.37) were collected. The median age was 53
years (range: 2–97). They consisted of 86, 484, 244, 240, and 219
sera collected from the districts of Jounine, Mateur, Ras Jabel,
Sejenane, and Utique, respectively (Figure 1). Detailed charac-
teristics of the tested sera are presented in Table 1.
TOSV neutralisation
Neutralising antibodies against TOSV (TOSV NT-Ab) were
detected in a total of 522 sera (41%): 96 had titre 10, 116 had titre
20, 165 had titre 40, and 145 had titre 80 (Table 2).
Author Summary
In northern Tunisia, two different pheboviruses are known
to circulate in sand fly population, Toscana virus (TOSV)
and Punique virus (PUNV). In contrast to TOSV, a
prominent human pathogen, there is no data supporting
that PUNV is capable to infect humans and to cause a
disease. We studied the respective involvement of TOSV
and PUNV in human infections in northern Tunisia through
a seroprevalence study. Because TOSV and PUNV are
antigenically and genetically closely related, it is difficult to
distinguish between them by using broadly reactive
serological tests, such as enzyme-linked immunosorbent
assay (ELISA). Thus, we developed a method of micro-
neutralisation assay using the two viruses in a comparative
manner. A total of 1,273 sera were processed. We provide
first evidence to support (i) that Punique virus may be
capable to infect humans but at a low rate, (ii) that TOSV,
the most prevalent arbovirus in Southern Europe, is
responsible for the vast majority of human infections by
sand fly-borne phleboviruses in northern Tunisia. There-
fore, it is important to consider TOSV as an important
pathogen that needs to be included in all virological
diagnostic concerning patients with meningitis and unex-
plained febrile illness originated from Northern Tunisia.
TOSV and PUNV in Tunisia: A Seroprevalence Study
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PUNV neutralisation
Neutralising antibodies against PUNV (PUNV NT-Ab) were
detected in a total of 111 sera (8.72%): 99 had titre 10, 11 had titre
20, 0 had titre 40 and 1 had titre 80 (Table 2).
Comparative analysis of TOSV and PUNV MN results
Results are presented in Table 2 and detailed analysis is given
as Text S1.
According to a 1:20 cut-off for positivity and four-fold
dilutions of difference, only five sera (bolded values in table 2)
reflected indisputable infection by PUNV, and a total of 414
sera (stared values in table 2) possessed TOSV NT-Ab
demonstrating infection by TOSV. For 144 sera (underlined
values in table 2), possible cross-neutralisation between PUNV
NT-Ab and TOSV NT-Ab precluded definitive interpretation
and conclusion.
These results suggested that the presence of TOSV NT-Ab may
be responsible for PUNV cross-neutralisation. As shown in
Table 3, PUNV MN titres are tightly correlated with previous
immunisation against TOSV, due to cross-neutralisation. In
contrast, TOSV MN titres are poorly impacted by PUNV MN
GMT, suggesting that the presence of TOSV MN NT-Ab can be,
Figure 1. Regions investigated for the seroprevalence study.
doi:10.1371/journal.pntd.0002429.g001
Table 1. Demographic characteristics of the panel of studied sera.
Nb of sera Sex ratio (M/F) Median age Nb of sera in age groups
0–20 21–40 41–60 .60 Unknown
Joumine 86 0,15 38 4 40 16 22 4
Mateur 484 0,37 57 30 100 154 194 6
Ras Jabel 244 0,31 50 16 66 102 60 0
Sejenane 240 0,61 53 17 65 68 88 2
Utique 219 0,33 52 2 74 75 68 0
Total 1273 0,37 53 69 345 415 432 12
doi:10.1371/journal.pntd.0002429.t001
TOSV and PUNV in Tunisia: A Seroprevalence Study
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in a large majority of cases, unequivocally attributed to TOSV
infection (Table 4).
District by district analysis of TOSV neutralising
antibodies
Detailed results of TOSV are presented globally for the 1,273
sera and for each region individually in Table 5, respectively. At
titre 10, 41% of sera contained antibodies capable to neutralise
TOSV. Among all districts of the Governorate of Bizerte,
seroprevalence rates varied from 17.2% to 59.4%. The lowest
seroprevalence rates were observed in the Ras Jabel district; the
two districts of Sejenane and Joumine exhibited intermediate rates
(30% and 40.7%); the highest rates were observed in the districts
of Mateur and Utique (50.2% and 59.4%). The proportions of sera
capable to neutralise TOSV at titre 10 were maintained when
analysis was performed at titres 20, 40 or 80.
GMT analysis by age group is presented in Figure 2. In Utique
and Joumine districts, the number of individuals in group 0–20
was too small to be compared with other age groups. So those two
points were not drawn in Figure 2. However, those individuals
were taken into account for analysis of the global population.
Analysis of GMT values on the global population (irrespective to
the district) demonstrated a constant increase according to the age.
Similar trends were observed in the Mateur, Sejenane and Ras
Jabel regions, independantly. In Utique and Joumine regions, the
GMT values were stable and decreased in the oldest group. These
differences with global population and other districts are not due
to the size of this age group; it might be due to a bias in the tested
population which is not representative of the global population.
Discussion
In the Mediterranean area, several phleboviruses are circulating
as demonstrated by virus isolation and/or molecular detection in
sand flies, and some of them (e.g. TOSV, Naples virus and Sicilian
virus) are recognised human pathogens [20]. TOSV is the leading
cause of CNS infection in Southern European countries [9,11].
Interestingly, the US military medical literature reported the
occurrence of sandfly fever in Northern Tunisia, namely in the
regions of Tunis, Ferryville, Mateur and Bizerte during WWII in
the US forces stationed in North Africa during the summer of
1943 [21]. The recent discovery of novel sand fly-borne
phleboviruses (Massilia virus, Granada virus, Punique virus) that
are antigenically and genetically closely related but clearly distinct
from TOSV demonstrated that at least two of these viruses can co-
circulate in a same geographic area [14,17]. These findings call for
further investigation to elucidate the potential effect of these newly
discovered phleboviruses on human health in these areas.
Although it is known that TOSV can infect humans and cause a
variety of clinical syndromes including neuro-invasive diseases,
there is no or very limited data about the capacity of these newly
discovered viruses to infect humans and to cause diseases.
In Tunisia, PUNV strains have been isolated from Phlebotomus
pernicisosus and Phlebotomus longicuspis collected from the district of
Utique where TOSV strains have been also isolated [13,17].
Therefore, the demonstration of co-circulation questioned their
respective role (if any) in human infections due to sand fly-borne
phleboviruses in Northern Tunisia. Both viruses belong to the
same virus species, Sandfly fever Naples, and consequently it is
difficult to distinguish between them by using broadly reactive
serological tests, such as inhibition hemagglutination assay,
complement fixation assay, enzyme-linked immunosorbent assay
(ELISA) or indirect immunofluorescence assay [6,13,18,22,23,24].
Indeed, serological cross-reactivity in a function of viral antigenic
closeness: the more similar the viruses, the more cross-reactive the
antibodies. The recent report of the presence of IgM and IgG
reactive against TOSV using ELISA test indicates that either
TOSV or an antigenic relative (such as PUNV) is involved in
human infection in Northern Tunisia [16,25]. However, the lack
of discrimination of ELISA cannot solve the problem of cross-
reactivity and thus cannot indisputably involve TOSV as the
etiologic agent of the CNS infections. The growing evidence that
distinct but antigenically related sand fly-borne phleboviruses
circulate in certain countries such as Spain (TOSV and Granada
virus), France (TOSV and Massilia virus), and Tunisia (TOSV and
PUNV) [9,10,13,14,15,17] pointed out to the cross-reactivity by
using ELISA, IFAT and subsequently lead to conducting studies
using neutralisation test which are the only assay with suitable
discriminative capacity [6,18,26].
To attempt the determination of the respective role of TOSV
and PUNV in human infection, a sero-epidemiological study
concerning a population living in endemic areas for visceral
leishmaniasis originated from Northern Tunisia was performed. A
total of 1,273 sera were tested using MN assay, with the two
Table 2. Detailed results of microneutralisation assays
against TOSV and PUNV.
Punique virus Total
No
neutralisation 1/10 1/20 1/40 1/80
Toscana
virus
No
neutralisation
710 36 4 0 1 751
1/10 89 7 0 0 0 96
1/20 106* 10 0 0 0 116
1/40 142* 21* 2 0 0 165
1/80 115* 25* 5* 0 0 145
Total 1162 99 11 0 1 1273
Bold values corresponded to sera reflecting infection by PUNV, stared values to
sera demonstrating infection by TOSV and underlined values to sera for which
cross-neutralisation precluded definitive conclusion.
doi:10.1371/journal.pntd.0002429.t002
Table 3. Correlation between microneutralisation titre for
Punique Virus (PUNV MN titre) and microneutralisation
geometric mean titre for Toscana virus (TOSV MN GMT).
PUNV (MN titre) 5 10 20 40 80
TOSV (MN GMT) 18,45 33,2 45,45 - 0
Number of sera 1162 99 11 - 1
doi:10.1371/journal.pntd.0002429.t003
Table 4. Correlation between microneutralisation titre for
Toscana Virus (TOSV MN titre) and microneutralisation
geometric mean titre for Punique virus (PUNV MN GMT).
TOSV (MN titre) 5 10 20 40 80
PUNV (MN GMT) 5,42 5,36 5,43 5,82 6,38
Number of sera 751 96 116 165 145
doi:10.1371/journal.pntd.0002429.t004
TOSV and PUNV in Tunisia: A Seroprevalence Study
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viruses independently. In agreement with other studies [27,28], we
determined an ‘‘a priori’’ cut-off value at titre 20, and analysed our
results according to the observed MN titre. The vast majority of
sera containing NT-Ab were found to be more reactive toward
TOSV than to PUNV. Previous infection by PUNV or a closely
related antigenic variant was undisputable for 5 sera. By contrast,
previous infection by TOSV was undisputable for 414 sera. This
demonstrates that although the two viruses are present in sand fly
populations, TOSV is involved at a much higher frequency in
human infection than PUNV. Interestingly, virus studies conduct-
ed on sand flies trapped in the same regions suggested that TOSV
circulates at lower level than PUNV, since the latter was detected
and isolated 6 times versus 2 times for TOSV of a total of 8,206
sand flies trapped during 3 successive seasons from 2008 to 2010
[13,17].
Our results indicate that PUNV (or closely related antigenic
variants) can infect humans, but it occurs seldom in a region where
the virus circulates at high level in sand fly populations. It should
be underlined that this does mean that PUNV is not capable to
cause human disease, but only that it is involved at a much lower
rate in human infections than TOSV in this region of Tunisia.
The clinical presentation associated with PUNV (mild, similar or
drastically different from TOSV infection) in humans is currently
unknown. Thus, its possible medical interest deserves further
investigations (e.g., by investigating summertime undetermined
febrile illness in the regions where the virus circulates).
Seroprevalence rates of TOSV NT-Ab observed in this study
(global rate 41%, 17.2% to 59.4% depending on the district) are
much higher than those (2–25%) reported in countries of southern
Europe such as Portugal, Spain, France, Italy, Greece and Turkey
[27,29,30,31,32,33]. Only few studies reported a seroprevalence
higher than the one observed in Tunisia: in the Tuscany region, a
seroprevalence of TOSV of 77.2% was reported among a
population at high-risk (forestry workers) [32]; in Greece
seroprevalence rates ranging from 39% to 51.7% were reported
in several islands [34]. Although this study was not performed with
a panel of sera representative of the population, it suggests that
TOSV circulates at much higher frequency than in southern
Europe. Similar studies should be performed in other regions of
Tunisia, but also in other North African countries to better
characterize this trend.
Analysis of GMT values on the global population demonstrated
a constant increase according to the age. Similar result were
reported in other studies concerning various populations from
endemic countries, where both anti-TOSV seroreactivity and
TOSV-specific antibody prevalence increased significantly with
Table 5. Results of seropositivity for TOSV MN, according to serum dilution and geographic origin.
No neutralisation (%) 1/10 (%) 1/20 (%) 1/40 (%) 1/80 (%) Total tested sera/Number of positive sera (%)
Joumine 51 (59.3) 10 (11.6) 4 (4.7) 18 (20.9) 3 (3.5) 86/25 (29.1)
Mateur 241 (49.8) 44 (9.1) 55 (11.4) 61 (12.6) 83 (17.1) 484/199 (41.1)
Ras Jabel 202 (82.8) 3 (1.2) 13 (5.3) 18 (7.4) 8 (3.3) 244/39 (16)
Sejenane 168 (70) 8 (3.3) 12 (5) 29 (12.1) 23 (9.6) 240/64 (26.7)
Utique 89 (40.6) 31 (14.2) 32 (14.6) 39 (17.8) 28 (12.8) 219/99 (45.2)
Total 751 (59) 96 (7.5) 116 (9.1) 165 (13) 145 (11.4) 1273/426 (33.5)
doi:10.1371/journal.pntd.0002429.t005
Figure 2. Geographic mean of titres for TOSV MN according to age groups.
doi:10.1371/journal.pntd.0002429.g002
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age [27,34,35]. This trend indicates that TOSV infection can
occur at any age of the life, and that repeated infections could play
a role in sustained and increasing immunity as reflected by
neutralising antibodies. These results deserve further confirmation
by studies addressing much larger populations covering wider
geographic areas.
In conclusion, this study conducted in Northern Tunisia
showed: (i) TOSV is responsible for the vast majority of human
infections by sand fly-borne phleboviruses, (ii) PUNV, a recently
discovered sand fly-transmitted phlebovirus that co-circulates with
TOSV, is capable of infecting humans but at a low rate, (iii)
important variations among seroprevalences are observed de-
pending on the geographic area, and thus on environmental
factors, and (iv) TOSV should be considered as an important
pathogen and that needs to be included in all virological diagnostic
concerning patients with meningitis and unexplained febrile illness
originated from Northern Tunisia.
Supporting Information
Text S1 Detailed analysis of table 2.
(DOC)
Checklist S1 STROBE Checklist.
(DOC)
Author Contributions
Conceived and designed the experiments: LB SS NS XdL EZ RNC.
Performed the experiments: LB SS MM NS KD SC XdL EZ RNC.
Analyzed the data: LB SS XdL RNC. Contributed reagents/materials/
analysis tools: NS IC LTMM SC. Wrote the paper: LB NS XdL EZ RNC.
References
1. Tesh RB, Saidi S, Gajdamovic SJ, Rodhain F & Vesenjak-Hirjan J (1976)
Serological studies on the epidemiology of sandfly fever in the Old World.
Bulletin of the World Health Organization 54: 663–674.
2. Nichol ST, Beaty BJ, Elliott RM, Goldbach R, et al. (2005) Virus Taxonomy:
Classification and Nomenclature of Viruses. Eighth Report of the International
Committee of the Taxonomy of Viruses. Elsevier Academic Press, Genus
Phlebovirus 709–716.
3. Maroli M, Feliciangeli MD, Bichaud L, Charrel RN, Gradoni L (2013).
Phlebotomine sandflies and the spreading of leishmaniases and other diseases of
public health concern. Med Vet Entomol 27(2):123–47.
4. Papa A, Konstantinou G, Pavlidou V, Antoniadis A (2006). Sandfly fever virus
outbreak in Cyprus. Clin Microbiol Infect 12(2):192–4.
5. Anagnostou V, Pardalos G, Athanasiou-Metaxa M, Papa A (2011). Novel
phlebovirus in febrile child, Greece. Emerg Infect Dis 17(5):940–1.
6. Dionisio D, Esperti F, Vivarelli A, Valassina M. (2003) Epidemiological, clinical
and laboratory aspects of sandfly fever. Curr Opin Infect Dis 16: 383–388.
7. Nicoletti L, Verani P, Caciolli S, Ciufolini MG, Renzi A et al. (1991) Central
nervous system involvement during infection by Phlebovirus toscana of residents
in natural foci in central Italy (1977–1988). Am J Trop Med Hyg 45(4): 429–34.
8. Valassina M, Cuppone AM, Bianchi S, Santini L, Cusi MG (1998) Evidence of
Toscana virus variants circulating in Tuscany, Italy, during the summers of 1995
to 1997. J Clin Microbiol 36(7): 2103–4.
9. Charrel RN, Gallian P, Navarro-Mari JM, Nicoletti L, Papa A et al. (2005)
Emergence of Toscana virus in Europe. Emerging Infectious Diseases 11: 1657–
1663.
10. Charrel RN, Bichaud L, De Lamballerie X (2012) Emergence of Toscana virus
in the mediterranean area. World J Virol 1(5): 135–141.
11. Jaijakul S, Arias CA, Hossain M, Arduino RC, Wootton SH et al. (2012)
Toscana meningoencephalitis: a comparison to other viral central nervous
system infections. J Clin Virol 55(3): 204–8.
12. Moureau G, Bichaud L, Salez N, Ninove L, Hamrioui B et al. (2010) Molecular
and serological evidence for the presence of novel phleboviruses in sandflies from
northern Algeria. Open Virology Journal 4: 15–21.
13. Zhioua E, Moureau G, Chelbi I, Ninove L, Bichaud L et al. (2010) Punique
virus, a novel phlebovirus, related to sandfly fever Naples virus, isolated from
sandflies collected in Tunisia. Journal of General Virology 91: 1275–1283.
14. Charrel RN, Moureau G, Temmam S, Izri A, Marty P et al. (2009) Massilia
virus, a novel Phlebovirus (Bunyaviridae) isolated from sandflies in the
Mediterranean. Vector Borne Zoonotic Diseases 9: 519–530.
15. Collao X, Palacios G, de Ory F, Sanbonmatsu S, Pe´rez-Ruiz M, et al. (2010)
Granada virus: a natural phlebovirus reassortant of the sandfly fever Naples
serocomplex with low seroprevalence in humans. Am J Trop Med Hyg 83(4):
760–5.
16. Bahri O, Fazaa O, Ben Alaya-Bouafif N, Bouloy M, Triki H et al. (2011) Role of
Toscana virus in meningo-encephalitis in Tunisia. Pathologie Biologique (Paris)
59: e125–e127.
17. Bichaud L, Dachraoui K, Piorkowski G, Chelbi I, Moureau G et al. (2013)
Toscana virus isolated from sandflies, Tunisia. Emerg Infect Dis 19(2): 322–4.
18. Ergu¨nay K, Litzba N, Lo MM, Aydog˘an S, Saygan MB et al. (2011)
Performance of various commercial assays for the detection of Toscana virus
antibodies. Vector Borne Zoonotic Dis 11(6): 781–7
19. Nougairede A, Bichaud L, Thiberville SD, Ninove L, Zandotti C et al. (2013)
Isolation of Toscana virus from the cerebrospinal 1 fluid of a man with
meningitis in Marseille, France, 2010. Vector Borne Zoonotic Dis. [In press].
20. Depaquit J, Grandadam M, Fouque F, Andry PE, Peyrefitte C (2010)
Arthropod-borne viruses transmitted by Phlebotomine sandflies in Europe: a
review. Euro Surveill 15(10): 19507.
21. Reilly William A, Escamilla Roberto F, Long Perrin H (1963) Internal Medicine
In World War II. Medical Department, United States Army. ; Vol II Infectious
Diseases, Chapt II Sandfly Fever.
22. Schwarz TF, Jager G, Gilch S, Pauli C (1995) Serosurvey and laboratory
diagnosis of imported sandfly virus, serotype Toscana, infection in Germany.
Epidemiol Infect 114: 501–510.
23. Magurano F. Nicoletti L (1999) Humoral response in Toscana virus acute
neurologic disease investigated by viral-protein-specific immunoassays. Clin
Diagn Lab Immunol 6: 55–60.
24. Cusi MG, Savellini GG. (2011) Diagnostic tools for Toscana virus infection.
Expert Rev Anti Infect Ther 9(7):799–805.
25. Sghaier W, Bahri O, Kedous E, Fazaa O, Rezig D et al. (2012) Retrospective
study of viral causes of central nervous system infections in Tunisia (2003–2009).
Med Sante Trop [In press].
26. Calisher CH. Beaty BJ. Chandler LJ (1999) Arboviruses. In: Lenette EH, editor;
Smith TF, editor. Laboratory Diagnosis of Viral Infections, 3rd edition. Revised
and Expanded. New York: Marcel Dekker 305–332.
27. Ergunay K, Aydogan S, Ilhami Ozcebe O, Cilek EE et al. (2012) Toscana virus
(TOSV) exposure is confirmed in blood donors from Central, North and South/
Southeast Anatolia, Turkey. Zoonoses Public Health 59(2): 148–54.
28. Navarro-Marı´ JM, Go´mez-Camarasa C, Pe´rez-Ruiz M, Sanbonmatsu-Ga´mez
S, Pedrosa-Corral I et al. (2013) Clinic-Epidemiologic Study of Human Infection
by Granada Virus, a New Phlebovirus within the Sandfly Fever Naples
Serocomplex. Am J Trop Med Hyg (5):1003–6.
29. Amaro F, Luz T, Parreira P, Ciufolini MG, Marchi A et al. (2011) [Toscana
virus in the Portuguese population: serosurvey and clinical cases]. Acta Med Port
24 Suppl 2: 503–8.
30. Sanbonmatsu-Ga´mez S, Pe´rez-Ruiz M, Collao X, Sa´nchez-Seco MP, Morillas-
Ma´rquez F et al. (2005) Toscana virus in Spain. Emerg Infect Dis 11(11): 1701–
7.
31. De Lamballerie X, Tolou H, Durand JP, Charrel RN (2007) Prevalence of
Toscana virus antibodies in volunteer blood donors and patients with central
nervous system infections in southeastern France. Vector Borne Zoonotic Dis
7(2): 275–7.
32. Valassina M, Valentini M, Pugliese A, Valensin PE, Cusi MG (2003) Serological
survey of Toscana virus infections in a high-risk population in Italy. Clin Diagn
Lab Immunol 10(3): 483–4.
33. Anagnostou V, Papa A (2013). Prevalence of antibodies to phleboviruses within
the sand fly fever Naples virus species in humans, northern Greece. Clin
Microbiol Infect 19(6):566–70.
34. Papa A, Andriotis V, Tzilianos M (2010). Prevalence of Toscana virus antibodies
in residents of two Ionian islands, Greece. Travel Med Infect Dis 8(5):302–4.
35. Terrosi C, Olivieri R, Bianco C, Cellesi C, Cusi MG (2009) Age-dependent
seroprevalence of Toscana virus in central Italy and correlation with the clinical
profile. Clin Vaccine Immunol 16(8): 1251–2.
TOSV and PUNV in Tunisia: A Seroprevalence Study
PLOS Neglected Tropical Diseases | www.plosntds.org 6 September 2013 | Volume 7 | Issue 9 | e2429
